Venus Concept Canada Corp.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Venus Concept Canada Corp. - overview
Established
2002
Location
Toronto, ON, Canada
Primary Industry
Medical Devices & Equipment
About
Venus Concept Canada Corp. specializes in the development and distribution of medical aesthetic equipment. Their innovative technologies support various non-invasive aesthetic treatments, enhancing client experiences in the medical aesthetics industry. Founded in 2002 and headquartered in Toronto, Canada, Venus Concept Canada Corp.
focuses on providing advanced medical aesthetic devices. The company's founders include Dr. Joy Shah and Oded Edoute, while Dhiraj Jaiswal serves as the CEO. To date, Venus has successfully completed 21 deals, with their most recent transactions occurring on December 22, 2020, involving a Private Placement/Follow on that raised USD 2.
00 mn, bringing the total amount raised to USD 2. 00 mn. Venus Concept Canada Corp. is engaged in developing and distributing a range of medical aesthetic equipment aimed at non-invasive treatments.
Their offerings include devices for body contouring, skin rejuvenation, and hair restoration. Core products such as Venus Bliss™, Venus Versa™, and Venus Legacy™ use advanced technologies like Robotics, AI, and energy-based solutions. The company serves a diverse client base, including medical spas and plastic surgeons, operating in over 60 countries and 11 direct markets, facilitating over 10 million treatments each year. In 2022, Venus Concept reported a revenue of USD 99.
50 mn, with an EBITDA loss of USD 30. 41 mn for the same year. The company generates revenue primarily through direct sales of medical aesthetic devices and associated training services, targeting partnerships with clinics and medical professionals to optimize technology use and enhance operational efficiency. Venus Concept aims to expand its product line with new devices designed to enhance treatment outcomes.
The company targets geographic expansion into emerging markets in Asia and Europe by 2025. Recent funding from the December 2020 IPO, where USD 22. 50 mn was raised, will support these initiatives, including product development and market entry strategies.
Current Investors
Essex Woodlands, HealthQuest Capital, Madryn Asset Management
Primary Industry
Medical Devices & Equipment
Sub Industries
Aesthetic Medicine, Surgical Devices, Medical Equipment Distributors
Website
www.venusconcept.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Venus Concept Canada Corp. - timeline of key events
Venus Concept Canada Corp. - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 17,200,000 | 15,600,000 | 21,297,000 | 21,956,000 | 110,406,000 | 78,014,000 | - | - | - |
| % Revenue Growth (YoY) | - | (9.3%) | 36.5% | 3.1% | 402.9% | (29.3%) | - | - | - |
| EBITDA (USD) | (19,700,000) | (18,300,000) | (16,157,000) | (24,623,000) | (28,238,000) | (63,094,000) | - | - | - |
| Operating Income (USD) | (20,500,000) | (18,900,000) | (17,282,000) | (25,906,000) | (30,278,000) | (67,898,000) | - | - | - |
| Operating Margin | (119.2%) | (121.2%) | (81.1%) | (118.0%) | (27.4%) | (87.0%) | - | - | - |
| % EBITDA Margin | (114.5%) | (117.3%) | (75.9%) | (112.1%) | (25.6%) | (80.9%) | - | - | - |
| NET Income (USD) | (23,000,000) | (21,800,000) | (17,842,000) | (28,726,000) | (42,295,000) | (82,818,000) | - | - | - |
| % Net Margin | (133.7%) | (139.7%) | (83.8%) | (130.8%) | (38.3%) | (106.2%) | - | - | - |
Venus Concept Canada Corp. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.